Mechanisms involved in the antiplatelet activity of magnesium in human platelets

British Journal of Haematology

Volumn 119, Issue 4, 2002, Pages 1033-1041

  Sheu, Joen Rong ^a   Hsiao, George ^a   Shen, Ming Yi ^a   Fong, Tsorng Harn ^a   Chen, Yi Win ^a   Lin, Chien Huang ^a   Chou, Duen Suey ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

GPIIb IIIa complex; Magnesium sulphate; Phospholipase C; Platelet aggregation; Protein kinase C

Indexed keywords

COLLAGEN; CYCLIC AMP; CYCLIC GMP; FIBRINOGEN RECEPTOR; FLUORESCEIN ISOTHIOCYANATE; LACTATE DEHYDROGENASE; MAGNESIUM SULFATE; NITRATE; PHOSPHATIDYLINOSITIDE; PROTEIN KINASE C; PROTEIN P47; THROMBOXANE A2; THROMBOXANE B2; TRIFLAVIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FLUORESCENCE; HUMAN; HUMAN CELL; MEMBRANE FLUIDITY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE;

BLOOD PLATELETS; CALCIUM; CELL CULTURE TECHNIQUES; COLLAGEN; CYCLIC AMP; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MAGNESIUM SULFATE; MEMBRANE FLUIDITY; PHOSPHATIDYLINOSITOLS; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBOXANE B2;

EID: 18744372392     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03967.x     Document Type: Article

References (34)

1. Berridge, M.J. (1983) Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochemical Journal, 212, 249-258.
2. Born, G.V.R. & Cross, M.J. (1963) The aggregation of blood platelets. Journal of Physiology, 168, 178-195.
3. Broekman, M.J., Ward, J.W. & Marcus, A.J. (1980) Phospholipid metabolism in phosphatidyl inositol, phosphatic acid and lysophospholipids. Journal of Clinical Investigation, 66, 275-283.
4. Charo, I.F., Feinman, R.D. & Detwiler, T.C. (1976) Inhibition of platelet secretion by an antagonist of intracellular calcium. Biochemical and Biophysical Research Communication, 72, 1462-1467.
5. Gawaz, M., Ott, I., Reininger, A.J. & Neumann, F.J. (1994) Effect of magnesium on platelet aggregation and adhesion. Thrombosis and Haemostasis, 72, 912-918.
6. Grabarek, J., Raychowdhury, M., Ravid, K., Kent, K.C., Newman, P.J. & Ware, J.A. (1992) Identification and functional characterization of protein kinase C isozymes in platelets and HEL cells. Journal of Biological Chemistry, 267, 10011-10017.
7. 2+ induces with greatly improved fluorescence properties. Journal of Biological Chemistry, 260, 3440-3450.
8. +2-binding properties of the platelet glycoprotein IIb ligand-interacting domain. Journal of Biological Chemistry, 267, 11001-11007.
9. Hass, W.K., Easton, J.D., Adams, H.P., Pryse-Philips, W., Molony, B.A., Anderson, S. & Kamm, B. (1989) A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. The New England Journal of Medicine, 321, 501-507.
10. 2 production. Biochemical Pharmacology, 31, 1158-1160.
11. Huang, T.F., Sheu, J.R. & Teng, C.M. (1991a) A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom. Biochemical Journal, 277, 351-357.
12. Huang, T.F., Sheu, J.R. & Teng, C.M. (1991b) Mechanism of action of a potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom. Thrombosis and Haemostasis, 66, 489-493.
13. Hwang, D.L., Yen, C.F. & Nadler, J.L. (1992) Effect of intracellular magnesium on platelet activation and intracellular calcium mobilization. American Journal of Hypertension, 5, 700-706.
14. Karniguian, A., Legrand, Y.J. & Caen, J.P. (1982) Prostaglandins: Specific inhibition of platelet adhesion to collagen and relationship with c AMP level. Prostaglandin, 23, 437-457.
15. Kitagawa, S., Shinohara, T. & Kametani, F. (1984) Effects of alcohols on ADP-induced aggregation and membrane fluidity of gel-filtered bovine blood platelets. Journal of Membrane Biology, 79, 97-102.
16. Lucas, M.J., Leveno, K.J. & Cunningham, F.G. (1995) A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. The New England Journal of Medicine, 333, 201-205.
17. McDonald, L.J. & Murad, F. (1996) Nitric oxide and cyclic GMP signaling. Proceedings of the Society for Experimental Biology and Medicine, 211, 1-6.
18. McKean, M.L., Smith, J.B. & Silver, W.J. (1981) Formation of lysophosphatidylcholine in human platelets in response to thrombin. Journal of Biological Chemistry, 256, 1522-1524.
19. Nadler, J.L., Goodson, S. & Rude, R.K. (1987) Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension, 9, 379-383.
20. Nadler, J., Malayan, S. & Luong, H. (1992) Evidence that intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care, 15, 835-841.
21. Pritchard, J.A. (1979) The use of magnesium sulfate in preeclampsia and eclampsia. Journal of Reproductive Medicine, 23, 107-114.
22. Rasmussen, H.S., McNair, P., Goransson, L., Balslov, S., Larsen, O.G. & Aurup, P. (1988) Magnesium deficiency in patients with and without acute myocardial infarction uncovered by an intravenous loading test. Archives of Internal Medicine, 148, 329-332.
23. Ravn, H.B., Vissinger, H., Kristensen, S.D. & Husted, S.E. (1996a) Magnesium inhibits platelet activity: An in vitro study. Thrombosis and Haemostasis, 76, 88-93.
24. Ravn, H.B., Vissinger, H., Kristensen, S.D., Wennmalm, A., Thygesen, K. & Husted, S.E. (1996b) Magnesium inhibits platelet activity: An infusion study in healthy volunteers. Thrombosis and Haemostasis, 75, 939-944.
25. Shechter, M., Sharir, M., Paul Labrador, M.J., Forrester, J., Silver, B. & Merz, N.B. (2000) Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation, 102, 2353-2358.
26. Sheu, J.R., Teng, C.M. & Huang, T.F. (1992) Triflavin, an RGD-containing antiplatelet peptide, binds to GP IIIa of ADP-stimulated platelets. Biochemical and Biophysical Research Communication, 189, 1236-1242.
27. Sheu, J.R., Chao, S.H., Yen, M.H. & Huang, T.F. (1994) In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice. Thrombosis and Haemostasis, 72, 617-621.
28. Sheu, J.R., Lin, C.H., Peng, C.H. & Huang, T.F. (1996) Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix protein via binding to multiple integrin receptors expressed on human hepatoma cells. Proceedings of the Society for Experimental Biology and Medicine, 213, 71-79.
29. Sheu, J.R., Hung, W.C., Wu, C.H., Ma, M.C., Kan, Y.C., Lin, C.H., Lin, M.S., Luk, H.N. & Yen, M.H. (1999) Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia. Circulation, 99, 3056-3062.
30. Sibai, B.M., Graham, J.M. & McCubbin, J.H. (1984) A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. American Journal of Obstetrics and Gynecology, 150, 728-733.
31. Siess, W. & Lapetina, E.G. (1989) Platelet aggregation induced by alpha 2-adrenoceptor and protein kinase C activation. A novel synergism. Biochemical Journal, 263, 377-385.
32. Walter, U., Eigenthaler, M., Geiger, J. & Reinhard, M. (1993) Role of cyclic nucleotide-dependent protein kinases and their common substrate VASP in the regulation of human platelets. Advances in Experimental Medicine and Biology, 344, 237-249.
33. Watson, K.L., Moldow, L.F., Ogburn, P.L. & Jacob, H.S. (1986) Magnesium sulfate: Rationale for its use in preeclampsia. Proceedings of the National Academy of Sciences of the United States of America, 83, 1075-1078.
34. Wroblewski, F. & Ladue, J.S. (1955) Lactic dehydrogenase activity in blood. Proceedings of the Society for Experimental Biology and Medicine, 90, 210-215.